Published by Abigail Townsend on 13th February 2024
(Sharecast News) - Citi has upgraded its rating on vaccines and drugs blue chip GSK to 'buy' while also boosting its earnings estimates.
URL: http://www.digitallook.com/dl/news/story/34082642/...